Gilead Widens Battle Against Alleged Counterfeit HIV Drug Ring

Gilead Widens Battle Against Alleged Counterfeit HIV Drug Ring
The logo of Gilead Sciences Inc. pharmaceutical company in Oceanside, Calif., on April 29, 2020. Mike Blake/Reuters
|Updated:

A federal judge in New York has frozen the assets of dozens of people and entities accused of operating a massive nationwide scheme to distribute counterfeit bottles of Gilead Sciences Inc. HIV drugs, including two alleged “kingpins.”

Gilead, which has been pursuing alleged counterfeiters in a civil lawsuit since last year, said in a court filing unsealed on Wednesday it had uncovered an operation that was “staggering in scope,” responsible for sales of hundreds of millions of dollars of counterfeit bottles of its top sellers Descovy, Genvoya, and Biktarvy, and other medicines.